Literature DB >> 12709350

Burkholderia is highly resistant to human Beta-defensin 3.

Hany Sahly1, Sabine Schubert, Jürgen Harder, Peter Rautenberg, Uwe Ullmann, Jens Schröder, Rainer Podschun.   

Abstract

The bactericidal activity of the novel beta-defensin hBD-3 against 28 species and 55 strains of gram-positive cocci and gram-negative fermentative and nonfermentative rods was tested. All strains proved to be highly or intermediately susceptible to hBD-3 (minimal bactericidal concentration [MBC], </=50 micro g/ml), except for Burkholderia cepacia, for all 23 tested strains of which MBCs were >100 micro g/ml.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12709350      PMCID： PMC153339          DOI： 10.1128/AAC.47.5.1739-1741.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  26 in total

1.  Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.

Authors:  E Mahenthiralingam; T Coenye; J W Chung; D P Speert; J R Govan; P Taylor; P Vandamme
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Current status of defensins and their role in innate and adaptive immunity.

Authors:  Periathamby Antony Raj; Andrew R Dentino
Journal:  FEMS Microbiol Lett       Date:  2002-01-02       Impact factor: 2.742

Review 3.  Role of membranes in the activities of antimicrobial cationic peptides.

Authors:  Robert E W Hancock; Annett Rozek
Journal:  FEMS Microbiol Lett       Date:  2002-01-10       Impact factor: 2.742

Review 4.  [beta]-defensins in lung host defense.

Authors:  Brian C Schutte; Paul B McCray
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

Review 5.  Cationic peptides: effectors in innate immunity and novel antimicrobials.

Authors:  R E Hancock
Journal:  Lancet Infect Dis       Date:  2001-10       Impact factor: 25.071

Review 6.  Persistent and aggressive bacteria in the lungs of cystic fibrosis children.

Authors:  C Anthony Hart; Craig Winstanley
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

7.  Antimicrobial defensin peptides of the human nasal mucosa.

Authors:  Sang Hag Lee; Jung Eun Kim; Hyun Ho Lim; Heung Man Lee; Jong Ouck Choi
Journal:  Ann Otol Rhinol Laryngol       Date:  2002-02       Impact factor: 1.547

8.  The novel human beta-defensin-3 is widely expressed in oral tissues.

Authors:  Anton Dunsche; Yahya Açil; Henrik Dommisch; Reiner Siebert; Jens M Schröder; Søren Jepsen
Journal:  Eur J Oral Sci       Date:  2002-04       Impact factor: 2.612

9.  Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic.

Authors:  J Harder; J Bartels; E Christophers; J M Schroder
Journal:  J Biol Chem       Date:  2000-11-20       Impact factor: 5.157

10.  Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction.

Authors:  J R García; F Jaumann; S Schulz; A Krause; J Rodríguez-Jiménez; U Forssmann; K Adermann; E Klüver; C Vogelmeier; D Becker; R Hedrich; W G Forssmann; R Bals
Journal:  Cell Tissue Res       Date:  2001-11       Impact factor: 5.249
View more
  24 in total

1.  Inner field compensation as a tool for the characterization of asymmetric membranes and Peptide-membrane interactions.

Authors:  Sven O Hagge; Andre Wiese; Ulrich Seydel; Thomas Gutsmann
Journal:  Biophys J       Date:  2004-02       Impact factor: 4.033

2.  Human beta-defensin 2 and beta-defensin 3 chimeric peptides reveal the structural basis of the pathogen specificity of their parent molecules.

Authors:  Sascha Jung; Justyna Mysliwy; Björn Spudy; Inken Lorenzen; Karina Reiss; Christoph Gelhaus; Rainer Podschun; Matthias Leippe; Joachim Grötzinger
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

3.  Identification of RNase 8 as a novel human antimicrobial protein.

Authors:  Bente Rudolph; Rainer Podschun; Hany Sahly; Sabine Schubert; Jens M Schröder; Jürgen Harder
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

4.  In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains.

Authors:  Giuseppantonio Maisetta; Giovanna Batoni; Semih Esin; Walter Florio; Daria Bottai; Flavia Favilli; Mario Campa
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 5.  Host defense peptides in wound healing.

Authors:  Lars Steinstraesser; Till Koehler; Frank Jacobsen; Adrien Daigeler; Ole Goertz; Stefan Langer; Marco Kesting; Hans Steinau; Elof Eriksson; Tobias Hirsch
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

6.  Macin family of antimicrobial proteins combines antimicrobial and nerve repair activities.

Authors:  Sascha Jung; Frank D Sönnichsen; Chien-Wen Hung; Andreas Tholey; Céline Boidin-Wichlacz; Wiebke Haeusgen; Christoph Gelhaus; Christine Desel; Rainer Podschun; Vicki Waetzig; Aurélie Tasiemski; Matthias Leippe; Joachim Grötzinger
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

7.  Decreased susceptibility of Staphylococcus aureus small-colony variants toward human antimicrobial peptides.

Authors:  Regine Gläser; Karsten Becker; Christof von Eiff; Ulf Meyer-Hoffert; Jürgen Harder
Journal:  J Invest Dermatol       Date:  2014-04-09       Impact factor: 8.551

8.  Activity of the novel peptide arminin against multiresistant human pathogens shows the considerable potential of phylogenetically ancient organisms as drug sources.

Authors:  René Augustin; Friederike Anton-Erxleben; Stephanie Jungnickel; Georg Hemmrich; Björn Spudy; Rainer Podschun; Thomas C G Bosch
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

9.  Antimicrobial properties of two purified skin peptides from the mink frog (Rana septentrionalis) against bacteria isolated from the natural habitat.

Authors:  Jonathan W Ashcroft; Zachary B Zalinger; Catherine R Bevier; Frank A Fekete
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2007-04-19       Impact factor: 3.228

10.  Mouse beta-defensin-14, an antimicrobial ortholog of human beta-defensin-3.

Authors:  Kerstin Hinrichsen; Rainer Podschun; Sabine Schubert; Jens M Schröder; Jürgen Harder; Ehrhardt Proksch
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.